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Yazmín Macotela, Brice Emanuelli, Marcelo A. Mori, Stephane Gesta, Tim J. Schulz, Yu-Hua Tseng,
and C. Ronald Kahn
Obesity and body fat distribution are important risk factors for
the development of type 2 diabetes and metabolic syndrome.
Evidence has accumulated that this risk is related to intrinsic
differences in behavior of adipocytes in different fat depots. In
the current study, we demonstrate that adipocyte precursor cells
(APCs) isolated from visceral and subcutaneous white adipose
depots of mice have distinct patterns of gene expression,
differentiation potential, and response to environmental and
genetic inﬂuences. APCs derived from subcutaneous fat differ-
entiate well in the presence of classical induction cocktail,
whereas those from visceral fat differentiate poorly but can be
induced to differentiate by addition of bone morphogenetic
protein (BMP)-2 or BMP-4. This difference correlates with major
differences in gene expression signature between subcutaneous
and visceral APCs. The number of APCs is higher in obesity-
prone C57BL/6 mice than obesity-resistant 129 mice, and the
number in both depots is increased by up to 270% by exposure of
mice to high-fat diet. Thus, APCs from visceral and subcutaneous
depots are dynamic populations, which have intrinsic differences
in gene expression, differentiation properties, and responses to
environmental/genetic factors. Regulation of these populations may
provide a new target for the treatment and prevention of obesity
and its metabolic complications. Diabetes 61:1691–1699, 2012
T
here are two main types of white adipose tissue
(WAT) in humans and rodents—subcutaneous
(SC) fat and visceral (intra-abdominal [Vis]) fat.
These contribute differentially to disease risk.
Accumulation of Vis adipose tissue is associated with ad-
verse metabolic outcomes, whereas increased amounts of
SC fat has been viewed as neutral or even beneﬁcial in its
metabolic effects (1–3). While part of this difference may
be related to anatomical location with different patterns of
venous drainage, over the past few years, it has become
clear that these two types of WAT differ in their intrinsic
characteristics, including levels of adipokine secretion,
insulin sensitivity, lipolysis rate, and tendency to develop
inﬂammation (4). We and others (5–7) recently have shown
that this correlates with differences in gene expression be-
tween adipocytes in different depots, including the expres-
sion of fundamental development and patterning genes.
Differences in differentiation and developmental gene
expression have also been observed in human pre-
adipocytes from different depots (8), but exactly how this
relates to intrinsic differences in adipose tissues and the
propensity for obesity and insulin resistance is unclear.
Spalding et al. (9) recently demonstrated that in humans,
;10% of the adipocyte pool turns over annually and that
the absolute number of adipocytes turning over in indi-
viduals with obesity is approximately double from that in
lean individuals. Exactly how adipocytes in different de-
pots turn over and to what extent this is inﬂuenced by
genetic or environmental factors is unknown. However,
using lineage tracing and ﬂuorescence-activated cell
sorting (FACS) strategies, two groups (10,11) have devel-
oped techniques to identify and isolate the adipocyte pre-
cursor cells (APCs) from the stromovascular fraction
(SVF) of white fat. In the current study, we show that APCs
are dynamic and respond to different environmental and
genetic factors. We show that APCs from Vis versus SC fat
differ in their speciﬁc gene expression signatures and that
SC APCs are more adipogenic and require fewer growth
factors, whereas Vis APCs have anti-adipogenic charac-
teristics and require additional growth factor stimulation
to differentiate. These results show that there are intrinsic
differences between preadipocytes from different depots
and that these differences contribute to the differential
properties and turnover of adipocytes in different depots.
RESEARCH DESIGN AND METHODS
Mice. C57BL/6 mice and 129 mice were obtained from The Jackson Laboratory
and kept under a normal diurnal cycle in a temperature-controlled room. Mice
werefedwithstandardchowcontaining22%ofcaloriesfromfat(MouseDiet9F
5020; PharmaServ) or a 60% high-fat diet (HFD) (OpenSource Diet D12492;
ResearchDiets).Forthe HFDversus chowdiet study, twocohortsof micewere
used starting at aged 3 and 8 weeks. Animal care and study protocols were
approved by the animal care committee of Joslin Diabetes Center and were in
accordance with National Institutes of Health guidelines.
Adipocyte precursor isolation and ﬂow cytometry. Epididymal and ingui-
nalfatpads,representingVisandSCfat,respectively,werecutinsmallpiecesand
incubated with 1 mg/mL collagenase I for 30min. The cell suspensionwasﬁltered
through a 150-mmol/L nylon mesh, and the SVF was isolated by low-speed
centrifugation. For FACS analysis, erythrocyte-free SVF cells were incubated
with a mix of antibodies against different surface markers as described previ-
ously (10) and sorted using an Aria ﬂow cytometer (BD Biosciences). Dead cells
were removed using propidium iodide staining. Cells negative for Ter119, CD45,
and CD31 and positive for both SCA1 and CD34 were considered as APCs.
Cell culture and differentiation of APCs. Cells were grown as described
previously (12) with some modiﬁcations. Medium containing 60% Dulbecco’s
modiﬁed Eagle’s medium–low glucose (Invitrogen) and 40% MCDB201 (Sigma-
Aldrich) and supplemented with Normocin 0.1 mg/mL (InvivoGen), 10% FBS,
13 insulin-transferrin-selenium mix, 13 linoleic acid conjugated to BSA,
1 nmol/L dexamethasone, and 0.1 mmol/L L-ascorbic acid 2-phosphate (Sigma-
Aldrich) was used as growth medium. This medium was further supplemented
with 10 ng/mL epidermal growth factor (PeproTech), 10 ng/mL leukemia inhibitory
factor (Millipore), 10 ng/mL platelet-derived growth factor BB (PeproTech),
and 5 ng/mL basic ﬁbroblast growth factor (Sigma-Aldrich). Once sorted, cells
were rinsed with medium and plated at 50,000 cells per well in 24-well plates.
After 6–7 days, cells reached ;80% conﬂuence. Medium was changed every
other day. For differentiation, cells were seeded at 20,000 cells per well in
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ORIGINAL ARTICLE48-well plates. After cells reached 80% conﬂuence, they were treated or not for
2 days with 3.3 nmol/L BMP-2 or BMP-4 (R&D Systems) in growth medium
with 2% FBS and without growth factors. Medium was then replaced by dif-
ferentiation medium (growth medium with no growth factors but with 2% FBS, 1
mmol/L dexamethasone, 0.5 mmol/L isobutylmethylxanthine, 100 nmol/L in-
sulin, and 1 mmol/L rosiglitazone) for 3 days, after which the medium was
replaced with growth medium containing 2% FBS and 100 nmol/L insulin for 2
more days; for the last 2–3 days of differentiation, cells were incubated with
growth medium with 2% FBS alone.
RNA extraction and PCR. RNA was extracted from cells using RNeasy
(QIAGEN). Reverse transcription was performed with 0.3 mg RNA by using High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA).
Real-time PCR was performed using Maxima SYBR Green (Fermentas, Glen
Burnie, MD) in duplicate using the ABI Prism 7900 System (Applied Biosystems)
under the following conditions: 50°C 22m i n ,9 5 ° C210 min, and 40 cycles of 95°C
215 s, 60°C 220 s, and 72°C 230 s. Dissociation protocols were conducted after
every run to check for primer speciﬁcity. To obtain relative expression values,
we calculated the 2
2DCt parameter for each individual sample using cycle
threshold values of TATA-box-binding protein as an endogenous control.
Microarray. Approximately 1 3 10
6 sorted cells per sample were used to
isolate RNA for the microarray analysis. Five independent RNA samples each
from a pool of isolated APCs from 10 different mice from each depot were
analyzed on Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara, CA). All
data were subjected to global normalization to an intensity of 1,500 using the
Gene Chip Software MAS V. 5.0. All differences reported had a P value ,0.05.
RESULTS
Isolation of APCs from different WAT depots. APCs
were isolated by FACS from SVFs of Vis and SC fat from
mice as described above and in Supplementary Fig. 1.
Cells negative for CD45, CD31, and Ter119 and positive for
CD34 and SCA1 were considered APCs. Cells positive for
CD45, CD31, and/or Ter119 (endothelial cells, platelets,
macrophages, white blood cells, osteoclasts, and eryth-
rocytes) were designated as “other SVF.” Only live cells were
counted. In a typical sorting, using male C57BL/6 mice aged
8 weeks, Vis fat contained 0.9 6 0.1 3 10
5 APCs and 3.5 6
0.8 3 10
5 other SVF cells per fat pad, whereas SC fat con-
tained 0.65 6 0.08 3 10
5 APCs and 7.1 6 0.7 3 10
5 other SVF
cells per pad (Fig. 1A). Thus, the percentage of stromovas-
cular cells, which are APCs, was almost three times higher in
Vis fat than in SC fat (21 6 3.7 vs. 7.8 6 1.7%) (Fig. 1B).
APCs from different fat depots differ in their
differentiation requirements. To conﬁrm that the iso-
lated APCs were preadipocytes, we analyzed the differ-
entiation ability of both Vis and SC APCs. Conﬂuent APC
cultures were treated with the typical induction protocol,
including rosiglitazone, and differentiation was assessed
by lipid accumulation and expression of markers of ter-
minal differentiation, including Slc2a4 (Glut-4), Adipoq
(adiponectin), Lep (leptin), and Fabp4 (fatty acid binding
protein or aP2). Using this approach, APCs from the SC fat
differentiated well within 7 days after induction, with .90%
of the cells containing large lipid droplets (Fig. 2A). In fact,
;10% of SC APCs differentiated in the absence of any
hormonal induction (Fig. 2A). By contrast, with the same
protocol, ,20% of APCs from the Vis depot could be in-
duced to differentiate (Fig. 2A). This raised two possibili-
ties: one was that the Vis APCs were not really adipocyte
precursors; the other was that the APCs were missing some
signals required for differentiation.
BMPs are known to induce commitment of mesenchymal
stem cells into adipocytes, muscle, and bone (13–15). We
hypothesized that perhaps BMP signaling was lacking in the
APCs from the Vis depot. We therefore pretreated subcon-
ﬂuent Vis and SC APCs with 3.3 nmol/L BMP-4 for 2 days
prior to the addition of the induction cocktail (IC) and then
assessed differentiation. With the SC APCs, BMP-4 pre-
treatment did not further enhance the almost complete dif-
ferentiation achieved by the IC alone (Fig. 2A). However,
with the Vis APCs, BMP-4 pretreatment markedly enhanced
differentiation, resulting in almost 90% of cells showing typ-
ical lipid droplets (Fig. 2A). Pretreatment with BMP-2 in-
duced Vis APCs to differentiate at a similar extent as BMP-4
(Fig. 2B) but had no further effect on SC APCs (not shown).
These differences in differentiation potential were con-
ﬁrmed by quantitative PCR analysis for expression of ter-
minal adipocyte differentiation genes. SC APCs 7–8 days
after treatment with standard IC with or without BMP-4
treatment showed marked increases in expression of Fabp4
(730-fold), Slc2a4 (300-fold), Adipoq (730-fold), and Lep
(20-fold) (Fig. 2C, right three bars, each panel). On the other
hand, Vis APCs treated with standard IC showed little ac-
cumulation of lipid and very small increases in expression
of these differentiation markers (Fig. 2C, left two bars, each
panel). However, when the Vis APCs were pretreated with
BMP-4 followed by IC, the increases in gene expression
were similar to those seen in SC APCs after differentiation,
with large increases in Fabp4 (480-fold), Slc2a4 (160-fold),
Adipoq (660-fold), and Lep (21-fold) (Fig. 2C, third bar, each
panel).
FIG. 1. Frequency of APCs and other SVF cells in SC vs. Vis depots. Typical FACS sorting analysis of APCs and other SVF cells from SC and Vis
depots isolated from male mice aged 7–9 weeks. Data were calculated using only live cells. Double positive CD34, SCA1 (and CD45
2, CD31
2, and
Ter119
2) cells were considered APCs, whereas CD45
+, CD31
+, and Ter119
+ cells were considered as other SVF cells. A: Number of cells per depot.
B: Percent of APCs in both depots relative to other SVF cells. Data are mean 6 SEM of n = 4 independent experiments. Statistics were analyzed by
Student t test (two-way, unequal variance). *P < 0.05.
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differentiation was at an early step involved in the stimu-
lation of PPARg. Thus, standard IC increased expression
of Cebpa by greater than twofold in APCs from both Vis
and SC fat, and Cebpa was not further increased by BMP-4
pretreatment (Fig. 2D). On the other hand, in SC APCs,
Pparg increased ﬁvefold after differentiation using standard
IC or BMP-4 plus IC. However, in Vis APCs, Pparg ex-
pression was not changed by treatment with IC but was
increased sixfold when cells were pretreated by BMP-4 plus
IC (Fig. 2D). Taken together, these data indicate that the
block in differentiation in Vis APCs lies in the inability of
standard induction hormones to trigger the expression of
Pparg and induce the transcriptional events required for
differentiation and that this block can be released by stim-
ulation of the BMP pathway. Since C/EBPa and PPARg can
regulate expression of each other in a positive feedback
manner (16) and since Cebpa is induced by standard IC in
Vis fat, the blockade appears to be in the ability of C/EBPa
to stimulate a normal increase in PPARg.
Proadipogenic gene expression signature in SC APCs.
To identify possible differences between adipocyte pre-
cursors isolated from SC and Vis depots that might con-
tribute to altered differentiation and other properties of
the adipocytes, we performed microarray analysis on
freshly isolated SC and Vis APCs from 7- to 8-week-old
mice. Consistent with their increased ability to differenti-
ate, when compared with Vis preadipocytes, SC APCs
showed signiﬁcantly higher expression of genes involved
in positive regulation of adipocyte differentiation, including
Pparg (3.2-fold), Cepba (1.3-fold), the dickkopf homolog
DKK2 (9.1-fold), Stat5a (2.9-fold), and the BMPs associated
with WAT differentiation, Bmp2 (1.5-fold) and Bmp4 (1.5-
fold) (all P , 0.05). By contrast, Vis APCs showed increased
expression of genes that can act as inhibitors of adipo-
cyte differentiation, including Gata2 (7.4-fold) and Tgfb2
(1.8-fold) (Table 1 and Supplementary Table 1). It is in-
teresting that APCs from the Vis depot also expressed
higher levels of markers found in bone marrow mesen-
chymal cells (17), including Lif, Igf1, Igfbp7, Ctgf, Mgp, Trib2
and Pgn1/Bgn (Table 1).
Depot-speciﬁc gene expression signatures. We (5,6)
and others (7,18,19) have previously shown that mature
adipocytes from Vis and SC fat have different patterns of
gene expression, including genes involved in adipocyte
function and developmental patterning. Comparing the
results from APCs in the current study with our previous
results in mature adipocytes from mice, we could identify
depot-speciﬁc signatures. These consisted of 19 genes that
were much more highly expressed in the Vis depot and
32 genes that were much more highly expressed in the SC
depot in both preadipocytes and adipocytes (Table 2).
Gene set enrichment analysis of the microarray data
showed that SC APCs have increased expression in three
major gene sets when compared with Vis APCs: 1)c h e -
mokines, 2)p e p t i d a s e s ,a n d3) proteins involved in the
FIG. 2. Higher differentiation capacity in APCs from SC than from Vis depots. After FACS sorting, APCs from SC and Vis depots were placed in
culture; upon 80% conﬂuence, they were treated with or without BMP2 or BMP4 and 2 days later, were induced to differentiate (insulin, iso-
butylmethylxanthine, dexamethasone, and rosiglitazone). Seven days after induction of differentiation, they were photographed to evaluate for lipid-
containing mature adipocytes (A and B) or lysed, mRNA extracted, and processed for quantitative PCR to evaluate expression changes on adipocyte
differentiation genes (C and D). Graphs show fold changes vs. N Vis. N, control without BMPs or IC; BMP4 IC, BMP4 pretreatment followed by IC.
Data are mean 6 SEM of n = 2 independent experiments. Statistics were analyzed by Student t test (two-way, unequal variance). *P < 0.05.
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APCs, the most enriched gene sets fell into four major
categories: 1) muscle related, with three related gene sets
myoﬁbril, sarcomere, and contractile ﬁber genes (P , 0.02);
2) monooxygenase activity; 3) developmental; and 4) negative
regulation of cytokine biosynthesis (Table 3).
Genes most differentially expressed between Vis and
SC APCs. The most differentially expressed gene, which
was highly expressed in Vis APCs, was the transcription
factor Tcf21, whereas in SC APCs, the most differentially
expressed gene was the transcription factor Lhx8 (LIM
homeobox 8). Another interesting gene with signiﬁcantly
higher expression in SC versus Vis APCs was Cd24. This
membrane protein was previously used as a surface marker
(10) to isolate the APCs from a mixture of Vis and SC white
fat depots. It is clear that this would result in preferential
isolation of the SC APCs from this mixed fat cell pool. A
heat map listing the 100 most differentially expressed genes
is shown in Supplementary Fig. 2.
Effect of sex, strain, and age on adipocyte precursor
frequency. To evaluate how the number of APCs and other
SVF cells change between different genetic and environ-
mental conditions, we analyzed APC frequency in young
(2-month-old) versus old (1-year-old) mice, in obesity-prone
(C57BL/6) versus obesity-resistant (129Sv/J) mice, and in
male versus female mice. Aging altered dramatically the
number of APCs. When expressed per gram of adipose tis-
sue, APC numbers were twofold higher in young than in old
mice in both depots (Fig. 3A). However, because fat mass
increases with age, the total number of APCs per depot was
increased by more than threefold in Vis and more than
fourfold in SC fat in old versus young mice. The number of
non-APCs (i.e., other SVF cells) per gram of fat was eight-
fold higher in SC fat of young versus old mice but similar in
both age-groups in the Vis depot (Fig. 3A). However, the
total number of other SVF cells per fat pad was almost
sixfold higher in Vis fat of old versus young mice, while it
remained similar in the SC depot between young and old
mice. Therefore, when the number of APCs was calculated
as the percentage of total SVF cells in each depot, young
mice had a signiﬁcantly higher percentage of APCs than old
mice in Vis fat (22 vs. 16%) but a smaller percentage of
APCs in SC fat than old mice (3 vs. 13%) (Fig. 3A).
It is interesting that obesity-prone C57BL/6 mice already
had almost twofold higher numbers of APCs per gram of
fat than 129 mice in both depots by age 3 months. C57BL/6
mice also had ninefold more other SVF cells per gram of
fat in the SC depot than 129 mice, whereas the number of
other SVF cells in the Vis depot was similar. However, the
percentage of APCs did not change between genotypes in
Vis fat but was higher in the SC fat from 129 mice than in
the same depot from C57BL/6 mice (17 vs. 4%) (Fig. 3B).
Between males and females, APCs and other SVF cells
per gram of fat or per depot did not differ signiﬁcantly.
However, male mice did have a twofold higher number of
other SVF cells in the Vis depot than female mice. As a re-
sult, the calculated percentage of APCs in the Vis depot
(but not in the SC depot) from female mice was almost
twice as high as that in males (29 6 3v s .1 56 2%) (Fig. 3C).
Effect of HFD on adipocyte precursor frequency in
young versus adult mice. Previous studies in humans
show that early onset obesity is associated with adipocyte
hyperplasia, whereas late onset of obesity is the result of
adipocyte hypertrophy and hyperplasia; studies in rodents
show hyperplasia can occur in both young and old animals
(20–22). To determine if HFD-induced obesity might alter
the number and percentage of APCs and other cells in the
SVF at different ages, we used two experimental paradigms:
one in which the HFD was started just after weaning
(3 weeks old) and a second in which mice were started on
the HFD as young adults (8–10 weeks old). As shown in
Fig. 4A and B, APC number increased after 2 and 4 weeks
on HFD in Vis and SC depots in both young and adult
mice; however, the increase in APCs was larger when the
mice were started on the HFD at a young age. Thus, Vis
APC numbers increased by 80 and 60% after 2 and 4 weeks
on HFD in young mice compared with 60 and 30% increases
in adult mice. This difference was more marked in SC APCs,
with 80 and 270% increases in cell numbers after 2 and
4 weeks on HFD in young mice compared with only 30
and 40% increases in adult mice. By contrast, the change
in other SVF cells was greatest in the Vis depot but similar
in young and adult mice, with increases of 210–270% in
both young and adult mice on the HFD, whereas the number
of other SVF cells in the SC depot increased modestly
(60 and 70% for young and adult mice, respectively). Thus,
HFD increases the number of other SVF cells only in the Vis
depot, consistent with the increase in inﬂammatory cells in
this compartment (23). When the percentage of APCs in the
depot was calculated, the percentage of APCs increased by
250 and 180% after 2 and 4 weeks on HFD in young animals
but was unchanged in adult animals. Thus, young pre-
pubertal mice have an increase in APCs on HFD that is
greater than that seen in adult animals, especially in the
SC depot (Fig. 4).
DISCUSSION
Adipose tissue serves as an important regulator of metabolic
homeostasis, and in this regard, not all fat is functionally
equivalent. Thus, accumulation of Vis fat is associated with
insulin resistance and a high risk for type 2 diabetes and
metabolic syndrome, whereas accumulation of SC fat has
been shown to have a possible protective value against
these metabolic abnormalities. This appears to relate to
TABLE 1
Pro- and anti-adipogenic gene expression signatures in Vis and
SC APCs
Fold P value
Proadipogenic genes higher
in SC APCs
Cepba 1.3 0.03
Pparg 3.2 0.0001
Dkk2 9.1 0.0004
Stat5a 2.9 0.0001
Bmp2 1.5 0.001
Bmp4 1.5 0.02
Anti-adipogenic genes higher
in Vis APCs
Gata2 7.4 0.0005
Tgfb2 1.8 0.01
Bone marrow mesenchymal cell
markers higher in Vis APCs
Lif 2.46 0.039
Igf1 2.2 0.00008
Igfbp7 2.07 0.00004
Ctgf 4.29 0.003
Mgp 11.88 0.003
Trib2 1.75 0.047
Pgn1/Bgn 1.77 0.000003
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(2,5,24–26). In the current study, we demonstrate that APCs
from SC and Vis fat have important differences in terms of
their gene expression signatures, their ability to differenti-
ate, their response to growth factors, and their regulation in
normal physiology and disease.
With regard to differentiation, previous studies show that
SVF cells taken from SC fat of either rodents or humans
differentiate more readily in culture than those from Vis fat
(26–28). We show that the same is true for isolated APCs
from these depots but ﬁnd that this is because the APCs
from SC and Vis depots have different differentiation
TABLE 2
Depot-speciﬁc signature of APCs and adipocytes from Vis and SC fat
Gene name
Fold difference
Gene symbol Adipo Preads Localization
Depot-speciﬁc signature—Vis
Angiotensinogen Agt 7.5 5.8 Secreted
Aldo-keto reductase family 1, member C12 Akr1c12 2.6 6.9 Cytoplasm
AMP deaminase 3 Ampd3 2.5 2.8 Cytoplasm
Anillin, actin binding protein (scraps homolog, Drosophila) Anln 5.3 2.8 Cytoplasm/Nucleus
Cysteine and glycine-rich protein 1 Csrp1 2.6 6.2 Nucleus
Cytochrome P450, family 1, subfamily b, polypeptide 1 Cyp1b1 11.0 3.2 ER/Microsomes
Hydroxyprostaglandin dehydrogenase 15 (NAD) Hpgd 2.2 2.0 Cytoplasm
Nuclear receptor subfamily 2, group F, member 1 Nr2f1 5.5 3.0 TF
Nuclear receptor subfamily 4, group A, member 1 Nr4a1 3.2 2.3 TF
Pterin 4 a carbinolamine dehydratase (TCF1) 1 Pcbd1 2.5 2.6 TF
Protocadherin 7 Pcdh7 2.6 2.1 PM
Plakophilin 2 Pkp2 2.9 2.8 PM
Prolactin receptor Prlr 3.8 2.9 PM
Serum amyloid A3 pseudogene Saa3p 2.6 5.2 Secreted
Solute carrier family 8, member 1 Slc8a1 2.3 4.2 PM
Secretory leukocyte peptidase inhibitor Slp1 3.1 18.7 Secreted
Serine/arginine-rich protein speciﬁc kinase 2 Srpk2 2.2 2.2 Cytoplasm/Nucleus
Thrombospondin 1 Thbs1 5.8 3.6 Secreted
Transcription factor 21 Tcf21 3.0 216.2 TF
Depot-speciﬁc signature—SC
Angiopoietin-like 1 Angptl1 3.5 2.1 Secreted
Apolipoprotein D Apod 3.8 2.0 Secreted
Chemokine (C-C motif) ligand 8 Ccl8 3.4 4.2 Secreted
Cadherin 2 Cdh2 2.9 2.5 PM
Cadherin 9 Cdh9 2.9 17.1 PM
Procollagen, type XII, a 1 Col12a1 3.4 3.4 Secreted
Procollagen, type I, a 1 Col1a1 4.7 3.3 Secreted
Early B-cell factor 3 Ebf3 2.0 4.1 TF
Engrailed 1 En1 8.0 4.5 TF
Estrogen receptor 1 (a) Esr1 2.5 3.0 TF
Fibroblast growth factor 13 Fgf13 2.1 3.8 Secreted
Fibronectin type III domain containing 1 Fndc1 2.9 2.0 Secreted
Histocompatibility 2, Q region locus 10 H2q10 4.2 10.8 Membrane
Interferon-g–inducible protein 47 Iﬁ47 4.0 2.8 ER/Membrane
Interferon-g–induced GTPase Igtp 2.0 2.4 Cytoplasm/Membrane
Interleukin-18 receptor 1 Il18r1 16.5 25.0 PM
Myelin basic protein Mbp 3.9 9.1 Nucleus/Cytoplasm/IntMem
Matrix metallopeptidase 3 Mmp3 3.5 21.5 Secreted
Major urinary protein 1 /// major urinary protein 2 Mup1/Mup2 375.1 3.6 Secreted
Major urinary protein 3 Mup3 63.5 10.3 Secreted
Osteomodulin Omd 3.8 2.4 Secreted
Procollagen C-endopeptidase enhancer protein Pcolce 2.8 2.9 Secreted
Protein disulﬁde isomerase associated 5 Pdia5 5.9 2.1 ER
Serine (or cysteine) peptidase inhibitor, clade F, member 1 Serpinf1 2.9 2.0 Secreted
Secreted frizzled-related protein 2 Sfrp2 5.4 2.6 Secreted
Short stature homeobox 2 Shox2 8.7 95.4 TF
Sine oculis-related homeobox 4 homolog (Drosophila) Six4 2.2 2.1 TF
ST6-N-acetylgalactosaminide a-2,6-sialyltransferase 5 St6galnac5 2.3 2.8 Golgi
T-box 15 Tbx15 12.2 145.4 TF
Transm prot with EGF-like and 2 follistatin-like domains 2 Tmeff2 3.0 2.0 PM
Ubiquitin D Ubd 5.7 2.3 Cytoplasm
Ubiquitin speciﬁc peptidase 18 Usp18 3.7 5.0 Cytoplasm
ER, endoplasmic reticulum; TF, transcription factor; PM, plasma membrane; IntMem, internal membrane.
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standard IC, Vis APCs differentiate very poorly under the
same conditions. However, pretreatment of Vis APCs with
BMP-4 or BMP-2 allows these cells to undergo full differ-
entiation. BMP-2 and BMP-4 have been shown to be re-
quired for commitment of the mesenchymal stem cell line
C3H10T1/2 to an adipocyte lineage (29), whereas com-
mitted cell lines, such as 3T3-L1, do not have this re-
quirement. Indeed, Vis APCs are more like mesenchymal
stem cells and less committed to adipocyte differentiation
than cells bearing the same surface markers from SC fat.
Vis APCs also show higher levels of expression of Gata2
TABLE 3
Gene set enrichment analysis
Gene set Gene symbol Gene name Fold change P value
Enriched in Vis APCs
Muscle related Des Desmin 5.5 0.000
Myoﬁbril Tpm2 Tropomyosin 2 (b) 3.6 0.020
Sarcomere Tpm1 Tropomyosin 1 (a) 2.5 0.000
Contractile ﬁber Myoz2 Myozenin 2 4.8 0.005
Tnnt2 Troponin T type 2 4.5 0.019
Tnni3 Troponin I type 3 2.4 0.019
Monooxygenase activity Pah Phenylalanine hydrogenase 18.8 0.000
Fmo2 Flavin containing monooxygenase 2 4.7 0.000
Cyp1b1 Cytochrome P450 family 1 subfamily b 3.2 0.000
Cyp27a1 Cytochrome P450 family 27 subfamily a 2.4 0.000
Fmo1 Flavin containing monooxygenase 1 2.1 0.000
Cyp7b1 Cytochrome P450 family 7 subfamily b 1.9 0.008
Developmental
Mesoderm development Tcf21 Transcription factor 21 216.2 0.000
Eya2 Eyes absent homolog 2 4.9 0.003
Slit2 Slit homolog 2 5.5 0.000
Mest Mesoderm speciﬁc transcript hom 1.6 0.010
Developmental maturation Rnd1 r family GTPase 1 2.7 0.001
Ereg Epiregulin 1.9 0.015
Pick1 Protein interacting with PRKCA1 1.4 0.006
Tgfb2 Transforming growth factor, b 2 1.8 0.010
Myh11 Myosin, heavy chain 11, s 1.9 0.040
Negative regulation of
cytokine biology Inhbb Inhibin, b B 8.6 0.001
Inhba Inhibin, b A 3.9 0.000
Ela2 Elastase 2 2.5 0.001
Il6 Interleukin 6 1.8 0.001
Enriched in SC APCs
Chemokines Cxcl9 Chemokine (C-C motif) ligand 9 5.3 0.001
Chemokine activity Cxcl14 Chemokine (C-X-C motif) ligand 14 4.2 0.002
Chemokine receptor binding Ccl8 Chemokine (C-C motif) ligand 8 4.2 0.000
Cxcl13 Chemokine (C-X-C motif) ligand 13 5.4 0.007
Cxcl10 Chemokine (C-X-C motif) ligand 10 1.9 0.000
Ccl22 Chemokine (C-C motif) ligand 22 5 0.007
Peptidase activity
Cysteine type endopeptidase
activity Lgmn Legumain 2.8 0.001
Casp9 Caspase 9 2.8 0.003
Ctsk Cathepsin K 1.7 0.000
Casp1 Caspase 1 1.9 0.009
Usp7 Ubiquitin speciﬁc peptidase 1.7 0.001
Uchl1 Ubiquitin carboxyl-terminal 1.3 0.010
Ctsb Cathepsin B 1.2 0.002
Aminopeptidase activity Trhde TRH-degrading enzyme 10.2 0.000
Lnpep Leucyl/cystinyl aminopeptidase 1.5 0.018
Anpep Alanyl (membrane) aminopeptidase 1.8 0.020
Vesicular fraction Stx16 Syntaxin 16 1.9 0.007
Microsome Mgst3 Microsomal gluthation S-transferase 3 1.7 0.001
Oas2 29-59-oligoadenylate synthetase 2 2.2 0.03
Ltc4s Leukotriene C4 synthase 4.5 0.04
Ero1lL ERO1-like 1.4 0.02
Slc35b1 Solute carrier family 35, member b1 1.3 0.02
Sts Steroid sulfatase 1.3 0.01
Tmed2 Transmembrane emp24 domain trafﬁcking protein 2 1.4 0.01
Copa Coatomer protein complex subunit a 1.5 0.001
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as well as higher levels of expression of mesenchymal
stem cell markers (Lif, Ctgf, and Mgp), whereas SC APCs
show higher expression of proadipogenic genes (Pparg,
Cebpa, Bmp2, Bmp4, and Dkk2). Thus, Sca1
+ and CD34
+
SC APCs are more committed to the adipocyte lineage
than Vis APCs expressing the same markers and have
fewer requirements for becoming mature adipocytes.
At a cellular level, this difference in differentiation is due
to a blockade in the ability of the IC to stimulate expres-
sion of Pparg. Thus, after treatment with IC, including the
PPARg agonist rosiglitazone, Vis APCs show increased
Cebpa but a failure of induction of Pparg and downstream
adipogenic markers. BMP-2 and BMP-4 signals overcome
the block and induce differentiation in Vis APCs. This may
be in part because SC APCs already have enough endoge-
nous BMP to trigger cell commitment, or it may depend
on other differences between the two adipocyte precursor
types. BMPs have been shown to induce Pparg through
activation of schnurri-2, which forms a transcriptional com-
plex with C/EBPa and SMAD1/4 (31). However, we ﬁnd no
difference in the level of schnurri-2 (Hivep2) between Vis and
SC fat. In any case, in the presence of BMP-2, BMP-4, and IC,
almost all of the Lin
2,C D 3 4
+, and SCA1
+ cells isolated from
both Vis and SC depots are able to become adipocytes,
indicating the isolated APCs from both depots do represent
the preadipocyte pool. This resistance to differentiation may
explain why Vis fat expansion during adulthood occurs
mainly by hypertrophy, whereas SC fat expansion is due
primarily to hyperplasia (32).
Although others have analyzed differences in gene ex-
pression between Vis and SC adipose tissue (5,19,33), ours
is the ﬁrst study to identify genes that are differentially
expressed between APCs in different depots. Tcf21 is the
most differentially expressed gene between Vis and SC
adipocyte precursors, with the higher levels in Vis cells.
This transcription factor also shows higher expression in
mature adipocytes of Vis fat (34). While Tcf21 has been
described (34) as a marker for white preadipocytes com-
pared with brown preadipocytes and muscle, in this study,
preadipocytes were isolated only from epididymal fat,
which have much higher expression than SC preadipocytes.
The levels of Tcf21 in SC preadipocytes are similar to those
in brown preadipocytes and muscle.
The most differentially expressed gene in SC APCs is the
LIM homeobox gene Lhx8. This gene had been previously
described as a marker for brown preadipocytes when ep-
ididymal fat was the only source of WAT (34). However,
Lhx8 is not unique to brown preadipocytes but also a strong
marker for SC preadipocytes (162-fold higher than in Vis
FIG. 3. Genetic and environmental impact on number (#) and percentage (%) of APCs and other SVF cells from Vis and SC fat depots. FACS sorting
analysis of Vis and SC APCs and other SVF cells. Data were calculated using only live cells. Double positive CD34, SCA1 (and CD45
2, CD31
2,a n d
Ter119
2) cells were considered APCs, whereas CD45
+,C D 3 1
+,a n dT e r 1 1 9
+ cells were considered as other SVF cells. A: 8-week-old vs. 1-year-old
C57BL/6 mice. m, month. B: C57BL/6 (B6) vs. 129 mice (3 months old). C: C57BL/6 male (M) vs. female (F) mice (6 months old). Five mice per group
were used in two independent experiments. Data are mean 6 SEM. Statistics were analyzed by Student t test (two-way, unequal variance). *P < 0.05.
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fat has several similarities with that of brown fat, as com-
pared with Vis white fat. Another gene more highly ex-
pressed in SC APCs than in Vis precursors is Cd24. This
membrane protein was previously used as a marker (10) to
purify the APCs but should probably not be used unless
one is attempting to separate different populations from
a mixture of white fat depots.
Our study also shows the dynamic nature of the adipo-
cyte precursor pool. We ﬁnd that HFD increases the num-
ber of APCs in both Vis and SC depots by as much as 270%.
The increase is bigger when animals are started on HFD at
a young age compared with when challenged as adults. Joe
et al. (32) reported a similar increase in bromodeoxyuridine
labeling of APCs in SC fat but a much smaller increase in
labeling of Vis fat after 60 days of HFD. Whether this reﬂects
differences in methodology, age of the mice, and a longer
period of HFD is unknown.
Another difference between depots after challenge with
HFD is that the number of non-APCs in the Vis depot
increases dramatically after 2–4 weeks on HFD, whereas
the number of other SVF cells in the SC depot remains
constant. This causes a dramatic change in the relative
proportion of cell types in these depots. Thus, the per-
centage of APCs in Vis fat decreases in mice on HFD
compared with those on chow diet, whereas the percent-
age of APCs in the SC depot either increases or remains
constant. This could explain why SC fat stays metaboli-
cally ﬁt in obesity, whereas Vis fat develops inﬂammation,
contributing to insulin resistance.
Fat mass increases with age, as does the number of
APCs per depot, by three- to fourfold or more. As with
HFD, however, the number of other SVF cells also increases,
especially in Vis fat. While sex has no effect on number of
APCs in the SC depot, females show a trend to increased
APCs and lower other SVF cells per gram of fat in Vis fat.
This could reﬂect a reduced number of macrophages in the
Vis depot of female mice and account for the higher insulin
sensitivity of adipocytes from Vis fat of females compared
with those from males (35).
Finally, the potential for new adipocytes also parallels
the genetic risk for obesity. Thus, the obesity-prone
C57BL/6 mouse has approximately twofold more APCs per
gram of fat than the obesity-resistant 129 mouse by age
3 months. In adult animals, this is accompanied by in-
creased content of lymphocytes and macrophages and
expression of proinﬂammatory genes in Vis fat of C57BL/6
mice, contributing further to the tendency of C57BL/6 mice
to develop insulin resistance upon aging or HFD-induced
obesity (36).
In conclusion, APCs from Vis and SC depots differ dra-
matically in terms of their differentiation ability, gene ex-
pression signatures, growth factor requirements, and
capacity to expand upon genetic and environmental stim-
uli. SC APCs are more committed to differentiate, whereas
those from Vis depots have an anti-adipogenic proﬁle and
require growth factors, such as BMP-2 or BMP-4, to un-
dergo differentiation. This helps explain why SC fat ex-
pands more by hyperplasia, whereas Vis fat expands by
hypertrophy. These depot-speciﬁc gene signatures can
serve as a powerful tool to identify and manipulate spe-
ciﬁc characteristics in the differentiation and functional
properties of adipocytes and ultimately should help us un-
derstand how these two fat depots have opposing contri-
butions to the development of diabetes and metabolic
syndrome.
FIG. 4. Effect of HFD on number (#) and percentage (%) of APCs and other SVF cells from Vis and SC fat depots. FACS sorting analysis of Vis and
SC APCs and other SVF cells. Data were calculated using only live cells. Double positive CD34, SCA1 (and CD45
2, CD31
2, and Ter119
2) cells were
considered APCs, whereas CD45
+, CD31
+, and Ter119
+ cells were considered as other SVF cells. FACS sorted cells from mice placed on chow diet
(CD) or HFD for 1, 2, and 4 weeks starting at age 4 weeks (A) or 8 weeks (B). Three to ﬁve mice per group were used in two independent
experiments. Data are mean 6 SEM. Statistics were analyzed by Student t test (two-way, unequal variance). *P < 0.05.
ADIPOCYTE PRECURSOR CELL SUBTYPES
1698 DIABETES, VOL. 61, JULY 2012 diabetes.diabetesjournals.orgACKNOWLEDGMENTS
This work was supported by National Institutes of Health
Grant R01-DK-082659 and the Mary K. Iacocca Professor-
ship. The study was also facilitated by support from the
Joslin Diabetes and Endocrinology Research Center Core
Laboratories (DK-036836). Y.M. was supported by the Pew
Latin American Fellows Program in the Biological Sciences,
the Mentor-Based American Diabetes Association Grant
Award, and the Mexican Council of Science (CONACyT)
Postdoctoral Fellowship. C.R.K. was supported by a grant
from the Loveman Foundation.
No potential conﬂicts of interest relevant to this article
were reported.
Y.M. conceived and designed the experiments, researched
data, and wrote the manuscript. B.E. researched data,
contributed to discussion, and reviewed and edited the
manuscript. M.A.M. and S.G. researched data and re-
viewed and edited the manuscript. T.J.S. set up the meth-
odology, contributed to discussion, and reviewed and
edited the manuscript. Y.-H.T. contributed to discussion
and reviewed and edited the manuscript. C.R.K. conceived
and designed the experiments, reviewed the data, and
wrote the manuscript. C.R.K. is the guarantor of this work
and, as such, had full access to all the data in the study and
takes responsibility for the integrity of the data and the
accuracy of the data analysis.
Parts of this study were presented in abstract form at the
70th Scientiﬁc Sessions of the American Diabetes Associ-
ation, Orlando, Florida, 25–29 June 2010.
The authors thank Joyce LaVecchio, Giri Buruzula, and
the Flow Cytometry core for help with cytometry; Joshua
Schroeder and the Genomics core for microarray process-
ing; Michael Rourk and Graham Smyth for their expertise
in animal care; and Madelana Basile and Jen Davison for
editing the manuscript (all from Joslin Diabetes Center).
REFERENCES
1. Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM.
Relationship of anterior and posterior subcutaneous abdominal fat to in-
sulin sensitivity in nondiabetic men. Obes Res 1997;5:93–99
2. Snijder MB, Dekker JM, Visser M, et al. Associations of hip and thigh
circumferences independent of waist circumference with the incidence of
type 2 diabetes: the Hoorn Study. Am J Clin Nutr 2003;77:1192–1197
3. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneﬁcial effects of sub-
cutaneous fat transplantation on metabolism. Cell Metab 2008;7:410–420
4. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-speciﬁc
hormonal characteristics of subcutaneous and visceral adipose tissue and
their relation to the metabolic syndrome. Horm Metab Res 2002;34:616–621
5. Gesta S, Blüher M, Yamamoto Y, et al. Evidence for a role of developmental
genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci
U S A 2006;103:6676–6681
6. Yamamoto Y, Gesta S, Lee KY, Tran TT, Saadatirad P, Kahn CR. Adipose
depots possess unique developmental gene signatures. Obesity (Silver
Spring) 2010;18:872–878
7. Cantile M, Procino A, D’Armiento M, Cindolo L, Cillo C. HOX gene network
is involved in the transcriptional regulation of in vivo human adipogenesis.
J Cell Physiol 2003;194:225–236
8. Tchoukalova YD, Koutsari C, Votruba SB, et al. Sex- and depot-dependent
differences in adipogenesis in normal-weight humans. Obesity (Silver
Spring) 2010;18:1875–1880
9. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover
in humans. Nature 2008;453:783–787
10. Rodeheffer MS, Birsoy K, Friedman JM. Identiﬁcation of white adipocyte
progenitor cells in vivo. Cell 2008;135:240–249
11. Tang W, Zeve D, Suh JM, et al. White fat progenitor cells reside in the ad-
ipose vasculature. Science 2008;322:583–586
12. Schulz TJ, Huang TL, Tran TT, et al. Identiﬁcation of inducible brown
adipocyte progenitors residing in skeletal muscle and white fat. Proc Natl
Acad Sci U S A 2011;108:143–148
13. Ahrens M, Ankenbauer T, Schröder D, Hollnagel A, Mayer H, Gross G.
Expression of human bone morphogenetic proteins-2 or -4 in murine mes-
enchymal progenitor C3H10T1/2 cells induces differentiation into distinct
mesenchymal cell lineages. DNA Cell Biol 1993;12:871–880
14. Bowers RR, Lane MD. A role for bone morphogenetic protein-4 in adipo-
cyte development. Cell Cycle 2007;6:385–389
15. Schulz TJ, Tseng YH. Emerging role of bone morphogenetic proteins in
adipogenesis and energy metabolism. Cytokine Growth Factor Rev 2009;
20:523–531
16. Rosen ED, Hsu CH, Wang X, et al. C/EBPalpha induces adipogenesis
through PPARgamma: a uniﬁed pathway. Genes Dev 2002;16:22–26
17. Igarashi A, Segoshi K, Sakai Y, et al. Selection of common markers for
bone marrow stromal cells from various bones using real-time RT-PCR:
effects of passage number and donor age. Tissue Eng 2007;13:2405–2417
18. Vohl MC, Sladek R, Robitaille J, et al. A survey of genes differentially
expressed in subcutaneous and visceral adipose tissue in men. Obes Res
2004;12:1217–1222
19. Tchkonia T, Lenburg M, Thomou T, et al. Identiﬁcation of depot-speciﬁc
human fat cell progenitors through distinct expression proﬁles and de-
velopmental gene patterns. Am J Physiol Endocrinol Metab 2007;292:
E298–E307
20. Salans LB, Cushman SW, Weismann RE. Studies of human adipose tissue.
Adipose cell size and number in nonobese and obese patients. J Clin Invest
1973;52:929–941
21. Hirsch J, Batchelor B. Adipose tissue cellularity in human obesity. Clin
Endocrinol Metab 1976;5:299–311
22. Lemonnier D. Effect of age, sex, and site on the cellularity of the adipose
tissue in mice and rats rendered obese by a high-fat diet. J Clin Invest 1972;
51:2907–2915
23. Wu H, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on
activation, normal T cell expressed and secreted upregulation in adipose
tissue in obesity. Circulation 2007;115:1029–1038
24. Hauner H, Entenmann G. Regional variation of adipose differentiation in
cultured stromal-vascular cells from the abdominal and femoral adipose
tissue of obese women. Int J Obes 1991;15:121–126
25. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabo-
lism. Part I: heterogeneity of adipose tissue and functional properties of
visceral adipose tissue. Diabetes Metab 2008;34:317–327
26. Tchkonia T, Giorgadze N, Pirtskhalava T, et al. Fat depot-speciﬁc char-
acteristics are retained in strains derived from single human pre-
adipocytes. Diabetes 2006;55:2571–2578
27. Prunet-Marcassus B, Cousin B, Caton D, André M, Pénicaud L, Casteilla L.
From heterogeneity to plasticity in adipose tissues: site-speciﬁc differ-
ences. Exp Cell Res 2006;312:727–736
28. Adams M, Montague CT, Prins JB, et al. Activators of peroxisome pro-
liferator-activated receptor g have depot-speciﬁc effects on human pre-
adipocyte differentiation. J Clin Invest 1997;100:3149–3153
29. Bowers RR, Kim JW, Otto TC, Lane MD. Stable stem cell commitment to
the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4
gene. Proc Natl Acad Sci U S A 2006;103:13022–13027
30. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. Function of
GATA transcription factors in preadipocyte-adipocyte transition. Science
2000;290:134–138
31. Jin W, Takagi T, Kanesashi SN, et al. Schnurri-2 controls BMP-dependent
adipogenesis via interaction with Smad proteins. Dev Cell 2006;10:461–471
32. Joe AW, Yi L, Even Y, Vogl AW, Rossi FM. Depot-speciﬁc differences in
adipogenic progenitor abundance and proliferative response to high-fat
diet. Stem Cells 2009;27:2563–2570
33. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N. Differ-
ential gene expression between visceral and subcutaneous fat depots.
Horm Metab Res 2002;34:622–628
34. Timmons JA, Wennmalm K, Larsson O, et al. Myogenic gene expression
signature establishes that brown and white adipocytes originate from
distinct cell lineages. Proc Natl Acad Sci U S A 2007;104:4401–4406
35. Macotela Y, Boucher J, Tran TT, Kahn CR. Sex and depot differences in
adipocyte insulin sensitivity and glucose metabolism. Diabetes 2009;58:
803–812
36. Mori MA, Liu M, Bezy O, et al. A systems biology approach identiﬁes in-
ﬂammatory abnormalities between mouse strains prior to development of
metabolic disease. Diabetes 2010;59:2960–2971
Y. MACOTELA AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 61, JULY 2012 1699